Board Meeting

SMS PHARMACEUTICALS LTD.

NSE : SMSPHARMABSE : 532815ISIN CODE : INE812G01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE211.15-2.8 (-1.31 %)
PREV CLOSE ( ) 213.95
OPEN PRICE ( ) 218.75
BID PRICE (QTY) 211.00 (1)
OFFER PRICE (QTY) 211.25 (2)
VOLUME 17551
TODAY'S LOW / HIGH ( )209.95 218.75
52 WK LOW / HIGH ( )75.1 219.3
NSE211.15-3.05 (-1.42 %)
PREV CLOSE( ) 214.20
OPEN PRICE ( ) 214.95
BID PRICE (QTY) 211.15 (229)
OFFER PRICE (QTY) 211.35 (66)
VOLUME 149440
TODAY'S LOW / HIGH( ) 209.95 216.70
52 WK LOW / HIGH ( )79.4 219.4

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.